Antiretroviral therapy for tuberculosis control in nine African countries. - Wikidata - wikimedia - TriplyDB

Antiretroviral therapy for tuberculosis control in nine African countries.

Antiretroviral therapy for tuberculosis control in nine African countries.

http://www.wikidata.org/entity/Q34320245

about

How can mathematical models advance tuberculosis control in high HIV prevalence settings?HIV and tuberculosis--science and implementation to turn the tide and reduce deaths Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'Implementing the global plan to stop TB, 2011-2015--optimizing allocations and the Global Fund's contribution: a scenario projections study Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness Estimation and Short-Term Prediction of the Course of the HIV Epidemic Using Demographic and Health Survey Methodology-Like Data Comparison of trends in tuberculosis incidence among adults living with HIV and adults without HIV--Kenya, 1998-2012 Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis.National and international policies to mitigate disease threats HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.Global epidemiology of tuberculosis.Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis.Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysis.Antiretroviral Treatment Scale-Up and Tuberculosis Mortality in High TB/HIV Burden Countries: An Econometric Analysis.The potential impact of new diagnostic tests on tuberculosis epidemics.Tuberculosis and HIV at the national level in Kenya: results from the Second Kenya AIDS Indicator Survey.Tuberculosis in Cape Town: An age-structured transmission model.Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV.The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission.Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.Potential impact of the US President's Emergency Plan for AIDS relief on the tuberculosis/HIV coepidemic in selected Sub-Saharan African countries.Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.Tuberculosis screening in high human immunodeficiency virus prevalence settings: turning promise into reality.Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings.Tuberculosis and HIV co-infection: screening and treatment strategies.Provision of antiretroviral therapy for HIV-positive TB patients--19 countries, sub-Saharan Africa, 2009-2013.The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis Incidence of Tuberculosis amongst HIV positive individuals initiating antiretroviral treatment at higher CD4 counts in the HPTN 071 (PopART) trial in South Africa.Can antiretrovirals curb southern Africa's HIV-associated TB epidemic?Does antiretroviral treatment increase the infectiousness of smear-positive pulmonary tuberculosis?Impact of Targeted Tuberculosis Vaccination Among a Mining Population in South Africa: A Model-Based Study.TB and HIV: deadly liaison or manageable threat?CD4 count and tuberculosis risk in HIV-positive adults not on ART: a systematic review and meta-analysis.The molecular epidemiology of tuberculosis in settings with a high HIV prevalence: implications for control.

P2860

Q26824057-3263CE59-8C38-4CE1-AD60-F71D970C68CE Q26824501-B0864E97-1B30-4EA2-8991-FB0D5E3D7D32 Q26828443-890CAB83-EB56-418F-A793-9BF211B89CB9 Q27015848-9700458D-337F-4FC3-860D-3525DF8E26A4 Q28480516-3D1449B6-EA5C-4405-AEF8-641A5284FC0C Q28485280-84D904CB-B61C-40F9-8397-43481B6F29AE Q28732179-18FB2CCF-9F1C-49E4-BCA6-CF24371878E3 Q30000083-DE6DF238-6356-4DA2-A74C-8D0B974B1584 Q33768889-8D0BF951-BC1A-4000-B72A-50C2449FC4C1 Q33795967-6096AC5C-1E17-4752-8083-9841AE6048F5 Q33847279-D9C39470-DE5E-464E-AD88-4084D64CCDB7 Q34299007-529E6776-3EFF-499A-8EC4-3D94830A7BD7 Q34339517-E21D593A-3B75-4063-8032-586F67563A65 Q34387168-97442C23-84CB-4F59-82AB-8E779265A3CB Q34999621-E6604C56-78AD-4D4D-B56B-06EA3FCEDF31 Q35045088-8377ACA1-621E-42AD-8550-3E8697B974AF Q35297467-C79466FA-FEE9-45FD-99C5-7FA366AD44E1 Q35584415-B13C2A14-92FE-40D8-98B9-ADAA217E59F4 Q36096194-062C480B-EE57-43BB-B3AC-FC3B39E2AE64 Q36106589-65CBA617-A7E5-41D6-BF93-A8D30ACF4E4A Q36107670-244F5872-2920-46A8-9CCD-848CEE89E38F Q36673080-68DAD50A-956C-4B6D-8F5A-DE6F4EBCE4E6 Q36686287-1BC785AC-F559-4D4E-98CA-BAF5E7F3E06F Q36950190-90C8DCFA-6771-465D-A46E-533EBF8F8917 Q37271760-37070DC8-F56D-4944-A220-14C0350A4DF5 Q37285167-A13CA182-8FC4-443F-9A5A-EB8FB8FA7570 Q37332200-FF27E6D9-3754-4799-AD9C-EB9832A96111 Q37461125-4E4F9270-20DF-4645-AA45-08F6F317094C Q37664997-50850234-2553-4258-AAC4-ED6DF4B438A0 Q37702101-BADE8AF8-96FB-4503-BDB5-5AB3EAC73723 Q37895251-0D93C867-948B-4AB2-98B8-66AC9F607132 Q38975257-5678FA1D-3C6E-4291-B8DE-293F328B02CA Q39003366-5C22533A-3536-4D0B-B7CE-C3A64F8C8316 Q41989084-445DE098-7EF5-427E-AA4D-2D1127C4C715 Q42391630-A74E352F-386B-4287-9097-AC12FF77F07B Q42687197-1D9B96CC-D5A9-43E7-BE17-0CF567CD3BF8 Q46271978-1CF0F3A0-24FC-4202-81D2-9EC39CCDD823 Q46300169-8BEEF264-0D1D-4750-B9D0-3C4840CE9C06 Q47094082-735334A0-4A5E-4D86-904E-C3A8D651AE01 Q51833634-129F6E84-0C0A-4BAD-9921-4FE55C60D089

P2860

Antiretroviral therapy for tuberculosis control in nine African countries.

http://www.wikidata.org/entity/Q34320245

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Antiretroviral therapy for tuberculosis control in nine African countries.

@en

Antiretroviral therapy for tuberculosis control in nine African countries.

@nl

type

label

Antiretroviral therapy for tuberculosis control in nine African countries.

@en

Antiretroviral therapy for tuberculosis control in nine African countries.

@nl

prefLabel

Antiretroviral therapy for tuberculosis control in nine African countries.

@en

Antiretroviral therapy for tuberculosis control in nine African countries.

@nl

P1433

Q34320245-2D422877-E40D-44B7-A502-F4366CAE07FE

P1476

Q34320245-6E47C3AB-1DE9-4547-87EA-43BC871DBEFD

P2093

Q34320245-340801AC-47DB-4BDD-8437-85DD77CFE6CA

Q34320245-58007D98-AF71-4E6E-932A-4924E247E94C

Q34320245-AC60FEC9-310B-4063-BA9B-442D9903BDAD

P2860

Q34320245-02B83C92-EA38-4083-9E25-61E2A0163A92

Q34320245-0B1408B5-44CA-4223-958A-AC7D9AA2C2D3

Q34320245-0B625DC5-4147-42B2-9D15-AED9E90DF5B8

Q34320245-13F70786-FA42-44DF-9CA7-2917F4B8A0B7

Q34320245-1CAB6763-6613-4085-ABCF-2CB1D7682D9C

Q34320245-1F537550-C78D-492E-B4B1-8E12A94FBA03

Q34320245-21AB42F5-EF36-4A4E-9D61-4CA80E92DE71

Q34320245-40BB3EDA-8A8F-4C76-9F99-837C65AE9C02

Q34320245-5606563E-CA50-4B2D-8EC1-B21F87DC4F00

Q34320245-5694AD23-C2C4-459E-8BFC-04A1695CB9C0

P304

Q34320245-D838472F-8A9B-43A7-AA86-39A29932833A

P31

Q34320245-A8921025-7A04-4366-A1D4-7E9BAF2A7C48

P356

Q34320245-AAE7FE86-7BF5-4F1F-986A-CED935C3B835

P407

Q34320245-F79C1705-D965-4E9A-B27C-1FD4A89F2BFC

P433

Q34320245-2847FA2B-8C68-4035-8EFA-6F606CC224BD

P478

Q34320245-E93F958A-FCCB-4626-872A-BEC4772455C8

P50

Q34320245-61856FC4-BC0B-4DDE-A13E-D35081DFDE96

Q34320245-98C5F327-6C79-4A64-A62E-B907680B6102

Q34320245-C0CE5D99-4B4D-4DDB-9E5D-87F17DEFDFDD

P577

Q34320245-462E27D7-BAE6-4ECE-9A50-EB73F01902CA

P5875

Q34320245-9292353A-C72E-441F-9F56-1F60224559EB

P698

Q34320245-3BB2FAC1-50B0-4F4E-8DF0-D7BAE05D21F0

P921

Q34320245-63BE4D18-6E2D-4A9F-B673-8147CA00F3D1

Q34320245-D7B707B8-CC4B-4DF7-8214-A1D0C6776420

P932

Q34320245-11B1D261-40BC-47B9-84E4-3F2844A8733B

P356

PNAS.1005660107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Antiretroviral therapy for tuberculosis control in nine African countries.

@en

P2093

Abhishek Sharma

http://www.w3.org/2001/XMLSchema#string

Kevin M De Cock

http://www.w3.org/2001/XMLSchema#string

Reuben Granich

http://www.w3.org/2001/XMLSchema#string

P2860

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.

Effect of early versus deferred antiretroviral therapy for HIV on survival.

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.

Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.

P304

19485-19489

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1005660107

http://www.w3.org/2001/XMLSchema#string

P407

P433

45

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Glaziou

Christopher Dye

P577

2010-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47544414

http://www.w3.org/2001/XMLSchema#string

P698

20974976

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

antiretroviral drug

P932

2984151

http://www.w3.org/2001/XMLSchema#string